Literature DB >> 23169986

Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis.

Thomas Pilgrim1, Bindu Kalesan, Peter Wenaweser, Christoph Huber, Stefan Stortecky, Lutz Buellesfeld, Ahmed A Khattab, Balthasar Eberle, Steffen Gloekler, Thomas Gsponer, Bernhard Meier, Peter Jüni, Thierry Carrel, Stephan Windecker.   

Abstract

BACKGROUND: Patients with severe aortic stenosis at increased surgical risk continue to experience compromised long-term survival despite successful transcatheter aortic valve implantation. We used time-related pathways in a multistate analysis to identify predictors of adverse long-term outcome in patients who underwent transcatheter aortic valve implantation. METHODS AND
RESULTS: In a cohort of 389 patients with a mean age of 82.4 ± 5.8 years and a STS score of 6.8 ± 5.3 undergoing transcatheter aortic valve implantation between 2007 and 2011, multistate analysis was used to estimate mortality and stroke taking into account intercurrent events including kidney injury and the composite of access site and bleeding complications (ABC). Transapical access emerged as a predictor of kidney injury (hazard ratio [HR], 2.12; 95% confidence interval [CI] 1.00-4.47) and ABC (HR, 1.78; 95% CI, 1.07-2.96), but had no impact on the risk of stroke or death. Body mass index ≤20 kg/m(2) increased the risk of stroke or death (HR, 2.64; 95% CI, 1.25-5.54). Age >80 years (HR, 3.15; 95% CI, 1.11-8.92), body mass index ≤20 kg/m(2) (HR, 4.11; 95% CI, 1.33-12.70), prior stroke (HR, 16.42; 95% CI, 3.63-74.21), and presence of atrial fibrillation at baseline (HR, 4.12; 95% CI, 1.87-9.97) increased the risk of stroke and death after an intercurrent event of ABC.
CONCLUSIONS: A body mass index ≤20 kg/m(2) was identified as a primary predictor of stroke and death after transcatheter aortic valve implantation during long-term follow-up, whereas transapical access emerged as a predictor of kidney injury and ABC. Age >80 years, body mass index ≤20 kg/m(2), prior stroke, and presence of atrial fibrillation at baseline increased the risk of stroke and death after an intercurrent event of ABC.

Entities:  

Mesh:

Year:  2012        PMID: 23169986     DOI: 10.1161/CIRCINTERVENTIONS.112.974899

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  13 in total

1.  How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial.

Authors:  Suzanne V Arnold; John A Spertus; Yang Lei; Philip Green; Ajay J Kirtane; Samir Kapadia; Vinod H Thourani; Howard C Herrmann; Nirat Beohar; Alan Zajarias; Michael J Mack; Martin B Leon; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

2.  gems: An R Package for Simulating from Disease Progression Models.

Authors:  Nello Blaser; Luisa Salazar Vizcaya; Janne Estill; Cindy Zahnd; Bindu Kalesan; Matthias Egger; Thomas Gsponer; Olivia Keiser
Journal:  J Stat Softw       Date:  2015-03       Impact factor: 6.440

3.  Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Authors:  Sabine Bleiziffer; Johan Bosmans; Stephen Brecker; Ulrich Gerckens; Peter Wenaweser; Corrado Tamburino; Axel Linke
Journal:  Clin Res Cardiol       Date:  2017-05-08       Impact factor: 5.460

4.  Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial).

Authors:  Nirat Beohar; Alan Zajarias; Vinod H Thourani; Howard C Herrmann; Michael Mack; Samir Kapadia; Philip Green; Suzanne V Arnold; David J Cohen; Philippe Généreux; Ke Xu; Martin B Leon; Ajay J Kirtane
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

5.  Development of a risk score for outcome after transcatheter aortic valve implantation.

Authors:  Moritz Seiffert; Jan-Malte Sinning; Alexander Meyer; Sandra Wilde; Lenard Conradi; Mariuca Vasa-Nicotera; Alexander Ghanem; Jörg Kempfert; Christoph Hammerstingl; Francisco M Ojeda; Won-Keun Kim; Dietmar H Koschyk; Johannes Schirmer; Stephan Baldus; Eberhard Grube; Helge Möllmann; Hermann Reichenspurner; Georg Nickenig; Stefan Blankenberg; Patrick Diemert; Hendrik Treede; Thomas Walther; Nikos Werner; Renate B Schnabel
Journal:  Clin Res Cardiol       Date:  2014-03-19       Impact factor: 5.460

6.  Feasibility and outcomes of combined transcatheter aortic valve replacement with other structural heart interventions in a single session: a matched cohort study.

Authors:  Ahmed A Khattab; Steffen Gloekler; Beate Sprecher; Samera Shakir; Enio Guerios; Stefan Stortecky; Crochan J O'Sullivan; Fabian Nietlispach; Aris Moschovitis; Thomas Pilgrim; Lutz Buellesfeld; Peter Wenaweser; Stephan Windecker; Bernhard Meier
Journal:  Open Heart       Date:  2014-06-27

Review 7.  Transcatheter Aortic Valve Implantation (TAVI): Is it Time for This Intervention to be Applied in a Lower Risk Population?

Authors:  Ioannis M Panayiotides; Evagoras Nikolaides
Journal:  Clin Med Insights Cardiol       Date:  2014-11-13

8.  Impact of age on transcatheter aortic valve implantation outcomes: a comparison of patients aged ≤ 80 years versus patients > 80 years.

Authors:  Frank van der Kley; Philippe J van Rosendael; Spyridon Katsanos; Vasileios Kamperidis; Nina A Marsan; Ioannis Karalis; Arend de Weger; Meindert Palmen; Jeroen J Bax; Martin J Schalij; Victoria Delgado
Journal:  J Geriatr Cardiol       Date:  2016-01       Impact factor: 3.327

9.  Performance of surgical risk scores to predict mortality after transcatheter aortic valve implantation.

Authors:  Leonardo Sinnott Silva; Paulo Ricardo Avancini Caramori; Antonio Carlos Bacelar Nunes Filho; Marcelo Katz; João Carlos Vieira da Costa Guaragna; Pedro Lemos; Valter Lima; Alexandre Abizaid; Flavio Tarasoutchi; Fabio S de Brito
Journal:  Arq Bras Cardiol       Date:  2015-07-31       Impact factor: 2.000

10.  A review of most relevant complications of transcatheter aortic valve implantation.

Authors:  Siyamek Neragi-Miandoab; Robert E Michler
Journal:  ISRN Cardiol       Date:  2013-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.